1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Japan’s Pharmaceutical Distribution Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Japan’s Pharmaceutical Distribution Market, by Service Type
8.1.1. Transportation & Logistics
8.1.1.1. Market Revenue and Forecast
8.1.2. Storage & Warehousing
8.1.2.1. Market Revenue and Forecast
8.1.3. Inventory Management
8.1.3.1. Market Revenue and Forecast
8.1.4. Cold Chain Management
8.1.4.1. Market Revenue and Forecast
8.1.5. Order Fulfillment
8.1.5.1. Market Revenue and Forecast
8.1.6. Value-added Services
8.1.6.1. Market Revenue and Forecast
9.1. Japan’s Pharmaceutical Distribution Market, by Distribution Model
9.1.1. Full-line wholesaling
9.1.1.1. Market Revenue and Forecast
9.1.2. Short-line Wholesaling
9.1.2.1. Market Revenue and Forecast
9.1.3. Direct-to-Pharmacy
9.1.3.1. Market Revenue and Forecast
9.1.4. Direct-to-Hospital
9.1.4.1. Market Revenue and Forecast
9.1.5. Third-party Logistics (3PL)
9.1.5.1. Market Revenue and Forecast
10.1. Japan’s Pharmaceutical Distribution Market, by Product Type
10.1.1. Prescription Drugs
10.1.1.1. Market Revenue and Forecast
10.1.2. Over-the-Counter (OTC) Drugs
10.1.2.1. Market Revenue and Forecast
11.1. Japan’s Pharmaceutical Distribution Market, by End User
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast
11.1.2. Retail Pharmacies
11.1.2.1. Market Revenue and Forecast
11.1.3. Clinics
11.1.3.1. Market Revenue and Forecast
11.1.4. Others (homecare, e-pharmacy)
11.1.4.1. Market Revenue and Forecast
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Service Type
12.3.7.2. Market Revenue and Forecast, by Distribution Model
12.3.7.3. Market Revenue and Forecast, by Product Type
12.3.7.4. Market Revenue and Forecast, by End User
13.1. AS ONE Corporation
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. WIN-Partners Co., Ltd.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Toho Holdings Co., Ltd.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Vital KSK Holdings, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Nippon Express Holdings
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Suzuken Co., Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Alfresa Holdings Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Mediceo Corporation
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. McKesson Corporation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. AmerisourceBergen Corporation
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
